Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 2508381, 13 pages
http://dx.doi.org/10.1155/2016/2508381
Research Article

A Computational Model of Peripheral Photocoagulation for the Prevention of Progressive Diabetic Capillary Occlusion

1School of Optometry, Indiana University, Bloomington, IN 47405, USA
2The Biocomplexity Institute, Indiana University, Bloomington, IN 47405, USA
3Physics Department, Indiana University, Bloomington, IN 47405, USA
4School of Informatics and Computing, Indiana University, Bloomington, IN 47408, USA

Received 21 April 2016; Revised 2 August 2016; Accepted 29 September 2016

Academic Editor: Steven F. Abcouwer

Copyright © 2016 Thomas J. Gast et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Diabetic Retinopathy Study Research Group, “Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group,” International Ophthalmology Clinics, vol. 27, no. 4, pp. 239–253, 1987. View at Publisher · View at Google Scholar
  2. “Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group,” Ophthalmology, vol. 98, no. 5, supplement, pp. 766–785, 1991. View at Publisher · View at Google Scholar
  3. “Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group,” Ophthalmology, vol. 88, no. 7, pp. 583–600, 1981. View at Publisher · View at Google Scholar
  4. C. Sanghvi, R. McLauchlan, C. Delgado et al., “Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures,” British Journal of Ophthalmology, vol. 92, no. 8, pp. 1061–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nagpal, S. Marlecha, and K. Nagpal, “Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser,” Retina, vol. 30, no. 3, pp. 452–458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Reddy, A. Hu, and S. D. Schwartz, “Ultra wide field fluorescein angiography guided targeted retinal photocoagulation (TRP),” Seminars in Ophthalmology, vol. 24, no. 1, pp. 9–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. K. Muqit, G. R. Marcellino, D. B. Henson et al., “Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy,” Acta Ophthalmologica, vol. 91, no. 3, pp. 251–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Fu, J. S. Gens, J. A. Glazier, S. A. Burns, T. J. Gast, and S. M. Peirce, “Progression of diabetic capillary occlusion: a model,” PLoS Computational Biology, vol. 12, no. 6, Article ID e1004932, 2016. View at Publisher · View at Google Scholar
  9. A. M. Joussen, V. Poulaki, W. Qin et al., “Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo,” American Journal of Pathology, vol. 160, no. 2, pp. 501–509, 2002. View at Google Scholar · View at Scopus
  10. B. Wierusz-Wysocka, H. Wysocki, H. Siekierka, A. Wykretowicz, A. Szczepanik, and R. Klimas, “Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus,” Journal of Leukocyte Biology, vol. 42, no. 5, pp. 519–523, 1987. View at Google Scholar · View at Scopus
  11. T. Arnould, C. Michiels, and J. Remacle, “Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1,” American Journal of Physiology—Cell Physiology, vol. 264, no. 5, part 1, pp. C1102–C1110, 1993. View at Google Scholar · View at Scopus
  12. M. Lu, V. L. Perez, N. Ma et al., “VEGF increases retinal vascular ICAM-1 expression in vivo,” Investigative Ophthalmology and Visual Science, vol. 40, no. 8, pp. 1808–1812, 1999. View at Google Scholar · View at Scopus
  13. M. Yanoff and J. S. Duker, Ophthalmology, Elsevier Saunders, 4th edition, 2014.
  14. M. B. Landers III, E. Stefansson, and M. L. Wolbarsht, “Panretinal photocoagulation and retinal oxygenation,” Retina, vol. 2, no. 3, pp. 167–175, 1982. View at Google Scholar · View at Scopus
  15. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” The New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Lange, Y. Yafai, A. Reichenbach, P. Wiedemann, and W. Eichler, “Regulation of pigment epithelium-derived factor production and release by retinal glial (Müller) cells under hypoxia,” Investigative Ophthalmology & Visual Science, vol. 49, no. 11, pp. 5161–5167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Mu, X.-M. Zhang, J.-J. Liu, L. Dong, and Z.-L. Feng, “Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells,” Molecular Biology Reports, vol. 36, no. 8, pp. 2147–2151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Wang, E. Xu, M. H. Elliott, M. Zhu, and Y.-Z. Le, “Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage,” Diabetes, vol. 59, no. 9, pp. 2297–2305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Poulaki, W. Qin, A. M. Joussen et al., “Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF,” The Journal of Clinical Investigation, vol. 109, no. 6, pp. 805–815, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. B.-H. Jiang, G. L. Semenza, C. Bauer, and H. H. Marti, “Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension,” American Journal of Physiology—Cell Physiology, vol. 271, no. 4, pp. C1172–C1180, 1996. View at Google Scholar · View at Scopus
  22. Y. Du, V. P. Sarthy, and T. S. Kern, “Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 287, no. 4, pp. R735–R741, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Li, S.-Z. Zhao, P.-P. Wang, S.-P. Yu, Z. Zheng, and X. Xu, “Calcium mediates high glucose-induced HIF-1α and VEGF expression in cultured rat retinal Müller cells through CaMKII-CREB pathway,” Acta Pharmacologica Sinica, vol. 33, no. 8, pp. 1030–1036, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. D. R. Mole, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe, “Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing,” IUBMB Life, vol. 52, no. 1-2, pp. 43–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Spitznas and N. Bornfeld, “The architecture of the most peripheral retinal vessels,” Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie, vol. 203, no. 3-4, pp. 217–229, 1977. View at Publisher · View at Google Scholar · View at Scopus
  26. M. H. Swat, G. L. Thomas, J. M. Belmonte, A. Shirinifard, D. Hmeljak, and J. A. Glazier, “Chapter 13-multi-scale modeling of tissues using CompuCell3D,” Methods in Cell Biology, vol. 110, pp. 325–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. P. Adamis, J. W. Miller, M.-T. Bernal et al., “Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 118, no. 4, pp. 445–450, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Malecaze, S. Clamens, V. Simorre-Pinatel et al., “Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 112, no. 11, pp. 1476–1482, 1994. View at Google Scholar · View at Scopus
  29. WHO, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
  30. G. P. Theodossiadis, A. Boudouri, G. Georgopoulos, and C. Koutsandrea, “Central visual field changes after panretinal photocoagulation in proliferative diabetic retinopathy,” Ophthalmologica, vol. 201, no. 2, pp. 71–78, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Buckley, L. Jenkins, and L. Benjamin, “Field loss after pan retinal photocoagulation with diode and argon lasers,” Documenta Ophthalmologica, vol. 82, no. 4, pp. 317–322, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Pahor, “Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation,” International Ophthalmology, vol. 22, no. 5, pp. 313–319, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. M. M. K. Muqit, L. Wakely, P. E. Stanga, D. B. Henson, and F. D. Ghanchi, “Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy,” Eye, vol. 24, no. 7, pp. 1136–1142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. L. Trick, L. R. Trick, and C. Kilo, “Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes,” Ophthalmology, vol. 97, no. 4, pp. 475–482, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Holm, M. Schroeder, and M. Lövestam Adrian, “Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema,” Documenta Ophthalmologica, vol. 131, no. 1, pp. 43–51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. B. E. Wolff, M. A. Bearse Jr., M. E. Schneck et al., “Color vision and neuroretinal function in diabetes,” Documenta Ophthalmologica, vol. 130, no. 2, pp. 131–139, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Heravian, N. Shoeibi, A. Azimi et al., “Evaluation of contrast sensitivity, color vision and visual acuity in patients with and without diabetes,” Iranian Journal of Ophthalmology, vol. 22, no. 3, pp. 33–40, 2010. View at Google Scholar · View at Scopus
  38. C. K. L. Chee and D. W. Flanagan, “Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy,” British Journal of Ophthalmology, vol. 77, no. 11, pp. 726–730, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Reichenbach and A. Bringmann, Müller Cells in the Healthy and Diseased Retina, Springer, New York, NY, USA, 2010. View at Publisher · View at Google Scholar